Informace o publikaci

Genomewide association study identifies no major founder variant in Caucasian moyamoya disease

Autoři

LIU Wanyang SENEVIRATHNA S.T.M.L.D. HITOMI Toshiaki KOBAYASHI Hatasu RODER Constantin HERZIG Roman KRAEMER Markus VOORMOLEN Maurits H.J. CAHOVÁ Pavlína KRISCHEK Boris KOIZUMI Akio

Rok publikování 2013
Druh Článek v odborném periodiku
Časopis / Zdroj Journal of genetics
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
Obor Neurologie, neurochirurgie, neurovědy
Klíčová slova Caucasian; founder variant; genomewide association study; moyamoya disease; suggestive association
Popis Moyamoya disease (MMD) is an idiopathic cerebrovascular occlusive-stenosis disorder at the terminal portion of internal carotid arteries and its main branches, accompanied by collateral vascular networks at the base of the circle of Willis (Takeuchi and Shimizu 1957; Suzuki and Takaku 1969). MMD has the highest prevalence in East Asian countries and a low prevalence in European countries (Goto and Yonekawa 1992; Kuroda and Houkin 2008). We have found that the p.R4810K variant in the ring finger protein 213 (RNF213) is a major founder susceptibility gene for East Asian MMD (Liu et al. 2010, 2011). In this study, we aimed to test whether there is a major founder susceptibility gene for Caucasian MMD using a genomewide association study (GWAS). We demonstrated that there was no major founder variant in Caucasian MMD as it is in East Asian MMD. We identified several suggestive association regions for Caucasian MMD.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info